Pharma channel feed – Endpoints News

Pharma channel feed

Regeneron to seek EUA for lower dose of Covid-19 mAb cocktail as new trial shows major drop in risk of hospitalization or death

5 years ago

Pfizer has run 41 trials over 15 years for tanezumab. As adcomm nears, the FDA remains unimpressed — and more than a little worried

5 years ago

PhRMA attacks New Mexico’s ‘short on detail’ plan for Canadian drug imports

5 years ago

Roche claims key win in the $12B early-stage checkpoint race

5 years ago

A packed MS market is about to get busier as J&J's ponesimod enters the fray

5 years ago

Merck breathes a sigh of relief as Keytruda-Lenvima combo aces confirmatory study in endometrial cancer

5 years ago

Drugmakers brace for a pricing fight as Xavier Becerra is confirmed as the next HHS secretary

5 years ago

Europe mulls halting Covid-19 vaccine exports to some countries

5 years ago

Court win for Eli Lilly halts HHS’s drug discount rule

5 years ago

FTC pledges to aggressively crack down on pharma mergers

5 years ago

Eli Lilly's IL-23 inhibitor mirikizumab shows late-stage promise in ulcerative colitis — but AbbVie's Skyrizi looms

5 years ago

BIO chair slams Trump’s HHS, calls to stop Russian disinformation campaign on vaccines

5 years ago

On a roll, Regeneron and Sanofi boast positive PhIII OS results in 'notoriously' tough cancer

5 years ago

Lilly disses Amgen and Mirati as it debuts new KRAS molecule

5 years ago

Recall report: BRP Pharma pulls 47 bottles of generic diuretic spironolactone after mixing different strength pills

5 years ago

Aveo Oncology gets the long-awaited greenlight to market tivozanib — 9 years after filing its first NDA

5 years ago

With profits lagging, Emma Walmsley, Big Pharma's only woman CEO, may once again be its lowest paid

5 years ago

Samantha Truex's Quench Bio calls it quits after failing to solve the Gasdermin D inflammation puzzle

5 years ago

Analysts picked the top 4 blockbuster contenders in the mix — and #1 is a $3.8B coin toss

5 years ago

Merck discard jumps straight to the top of the chart of the most expensive drugs in the US at $1M-plus

5 years ago

Gilead's Biktarvy build its case for long-term use with 4-year data showing lasting HIV suppression

5 years ago

Roche withdraws Tecentriq in bladder cancer amid FDA's sweeping review on accelerated approvals

5 years ago

Focusing on the bright side, FDA OKs Roche's Actemra for rare lung disease despite PhIII flop

5 years ago

Latest MassBio report shows just how much biopharma's biggest sector boomed in 2020

5 years ago

First page Previous page 251 252 253254255 256 257 Next page Last page